Home » Topics » BioWorld

BioWorld
RSS

IMMUNEX TESTS TNF CANDIDATE FOR SEPSIS

July 21, 1992

IG, GENZYME BUY VIVIGEN FOR $40M

July 21, 1992

CALGENE ACQUIRES OLEOCHEMICAL PRODUCER

July 21, 1992

BOSTON BIOMEDICA BUYS CBCX DIVISION

July 21, 1992

AMSTERDAM AIDS CONFERENCE: VACCINE INCITES ANTIBODIES TO HIV-1

July 21, 1992

APPOINTMENTS AND ADVANCEMENTS

July 20, 1992

CALCIUM CHANNEL TO BRAIN CELLS CLONED

July 20, 1992

STOCK INDEXES POISED TO START TRADING

July 20, 1992

BTGC SCOUTS NEW PARTNER FOR hGH EUROPE

July 20, 1992

GENZYME READY FOR BURN TREATMENT TRIALS

July 17, 1992

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 8, 2026.
‘Target-high but uptake-defective’ state identified in ADC resistance
BioWorld
Separate research teams have reported new insights into resistance mechanisms to the antibody-drug conjugate (ADC) Padcev (enfortumab vedotin, Astellas Pharma...
Hyperexcitability may be joint problem in epilepsy, dementia
BioWorld
The majority of epilepsies are developmental disorders that start in childhood. But there is a large minority that starts in late adulthood. And increasingly,...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
GDE4 blockade promotes remyelination, study finds
BioWorld Science
Myelin is crucial for the correct functioning of nerve signaling and its loss is a feature of neurological disorders. The cells responsible for myelination in the...